New pill shows promise for Hard-to-Treat blood cancer in early japanese study
Disease control
Completed
This early-phase study tested a new oral drug called ME-401 in 14 Japanese patients with a slow-growing form of non-Hodgkin's lymphoma that had returned or stopped responding to prior treatments. The main goals were to check the drug's safety, find the right dose, and see how the…
Phase: PHASE1 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC